Because of the extensive upfront strategy and financial due diligence needs and multi-year post-merger integration/divestiture opportunities, it's often been said that as goes the M&A market so goes consulting demand. If Schaffer Consulting's M&A practice leader Rick Heinick is correct, there's reason to think the current recovery will have legs. Consulting One on One recently sat down with Heinick to learn more about M&A consulting demand.
Consulting: Based on what you're seeing in the marketplace, how is M&A tracking?
Heinick: It's clear that access to capital has improved and mergers are on the increase. We're seeing a big surge in M&A activity in life sciences—pharmaceutical companies buying biotech companies, biotechs buying smaller biotechs and then selling to pharma companies. companies. There's a lot of activity across industries.
To continue reading, become an ALM digital reader
Benefits include:
- Authoritative and broad coverage of the business of consulting
- Industry-leading awards programs like Best Firms to Work For, Global Leades and Rising Stars
- An informative newsletter that goes into the trends shaping the industry
- Critical coverage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
